Compass Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Compass Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Compass Therapeutics Inc
Rating: 0.99850
Author: Trendlyne DVM scores

about

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationshi...

2.22 0.07 (3.26%)

67.73% Fall from 52W High

4.2M

XNAS Volume

XNAS 10 Aug, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Compass Therapeutics Inc is on 18 Aug 2026 for the purpose of Compass Therapeutics Inc Second Quarter Earnings Result for 2026 See details

Not Eligible

Expensive Valuation

10.0 / 100

Technically Bearish

29.9 / 100

1Yr Price target upside is 514%

14 analysts

Compass Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Compass Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationshi...

67.73% Fall from 52W High

SWOT Analysis

Compass Therapeutics Inc Live Price Chart

Compass Therapeutics Inc Live Price Chart